LinkDoc Technology Limited IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| LinkDoc Technology Limited | LDOC - NASDAQ |
Postponed | $0.00 | $0.00 | Postponed | 7/9/2021 |
| Morgan Stanley, BofA Securities, CICC | ||||||
Co-Manager(s): Tiger Brokers, Snowball | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-06-14 Terms Added 2021-07-01 | ||||||
About LinkDoc Technology Limited (adapted from LinkDoc Technology Limited prospectus):
They are a leading data-driven and AI-enabled healthcare technology company in terms of first-mover in cultivating high-quality medical data assets with the largest set of China oncology cohorts, according to Frost & Sullivan.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a leading data-driven and AI-enabled healthcare technology company in terms of first-mover in cultivating high-quality medical data assets with the largest set of China oncology cohorts, according to Frost & Sullivan.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "LDOC" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.